Cargando…
Lipidated promiscuous peptide augments the expression of MHC-II molecules on dendritic cells and activates T cells
BACKGROUND & OBJECTIVES: In spite of the fact that BCG is the most widely used vaccine, tuberculosis (TB) continues to be a major killer disease in TB-endemic regions. Recently, many emerging evidences from the published literature indicate the role of environmental mycobacteria in blocking the...
Autores principales: | Gowthaman, Uthaman, Rai, Pradeep K., Zeng, Weiguang, Jackson, David C., Agrewala, Javed N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928704/ https://www.ncbi.nlm.nih.gov/pubmed/24434326 |
Ejemplares similares
-
A novel therapeutic strategy of lipidated promiscuous peptide against Mycobacterium tuberculosis by eliciting Th1 and Th17 immunity of host
por: Rai, Pradeep K, et al.
Publicado: (2016) -
A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis
por: Rai, Pradeep K., et al.
Publicado: (2018) -
Potential T cell epitopes of Mycobacterium tuberculosis that can instigate molecular mimicry against host: implications in autoimmune pathogenesis
por: Babu Chodisetti, Sathi, et al.
Publicado: (2012) -
Manipulation of Costimulatory Molecules by Intracellular Pathogens: Veni, Vidi, Vici!!
por: Khan, Nargis, et al.
Publicado: (2012) -
A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity
por: Rai, Pradeep K., et al.
Publicado: (2017)